1. Corporate Officers - G
2. Glickman Mark A

Insider Trading History of Glickman Mark A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Glickman Mark A since 2014. This trader's CIK number is 1441461. At the time of last reporting, Glickman Mark A was the Co-Chief Executive Officer of Therapeuticsmd, Inc.. (stock ticker symbol TXMD). Also see all insider trading activities at Therapeuticsmd, Inc..

Note that in the past Glickman Mark A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Auxilium Pharmaceuticals Inc (AUXL) by Glickman Mark A

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2014	AUXL	0	$0	47,952	$1,590,615	40,750	$886,190

Yearly summary of insider trading at Aralez Pharmaceuticals Inc. (ARLZ) by Glickman Mark A

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2018	ARLZ	0	$0	5,725	$9,732	0	$0
2016	ARLZ	25,000	$92,050	0	$0	0	$0

Yearly summary of insider trading at Therapeuticsmd, Inc. (TXMD) by Glickman Mark A

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2022	TXMD	0	$0	440	$2,165	1,734	$0

Insider trading activities at 3 companies by Glickman Mark A:

1. Auxilium Pharmaceuticals Inc (AUXL)

2. Aralez Pharmaceuticals Inc. (ARLZ)

3. Therapeuticsmd, Inc. (TXMD)

Table 1. Insider trading of Auxilium Pharmaceuticals Inc (AUXL) by Glickman Mark A

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2014-11-20	AUXL	Sale	47,952	33.17	1,590,615
2014-11-20	AUXL	Option Ex	40,750	21.75	886,190

Table 2. Insider trading of Aralez Pharmaceuticals Inc. (ARLZ) by Glickman Mark A

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2018-03-19	ARLZ	Sale	5,725	1.70	9,732
2016-05-16	ARLZ	Buy	25,000	3.68	92,050

Table 3. Insider trading of Therapeuticsmd, Inc. (TXMD) by Glickman Mark A

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2022-12-06	TXMD	Sale	440	4.92	2,165
2022-12-06	TXMD	Option Ex	1,734	.00	0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Glickman Mark A (Co-Chief Executive Officer of Therapeuticsmd, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month